Efficacy and Safety of Surgical Treatment for Type IVa CBD

Recruiting now

Conditions studied: Choledochal Cyst

In brief

This study is a multicenter, bidirectional cohort study aimed at continuously enrolling patients with biliary dilatation from 25 medical centers in China. It will collect comprehensive life-cycle data from the cohort to establish a Chinese cohort for IVa biliary dilatation (BD). Based on this cohort, the study seeks to compare the perioperative risks, long-term outcomes, and quality of life of type IVa BD following surgical treatment, to establish standardized surgical treatment strategies for type IVa BD.

Key facts

Study ID

NCT07036848

Run by

Beijing Tsinghua Chang Gung Hospital

People needed

1500

Starts

2025-07-14

Expected to finish

2035-07-01

Last updated by the study team

2025-07-17

Who can join

Age: any, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients who have been diagnosed with Todani type IVa BD.
• Patients aged between 0 and 80 years old, regardless of gender.
• First-time receipt of surgery.

You may not qualify if…

• With abnormal intrapancreatic bile duct
• Inappropriate Roux-loop length (outside the range of 40-60 cm for adults and 15-30 cm for children)
• With non-relevant surgical interventions
• Pathologically confirmed carcinogenesis
• Unresolved choledocholithiasis, bile duct stenosis, and Intrahepatic bile duct stones during the procedure.
• Unavailable follow-up information.

Where it is running

• Beijing Tsinghua Changgung Hospital — Beijing, Beijing Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.